Pseudomonas aeruginosa Isolated from the Environment of a Veterinary Academic Hospital in Brazil - Resistance Profile

Background: The presence of resistant and potentially virulent bacterial strains in a veterinary hospital environment is a neglected problem. Pseudomonas aeruginosa is an opportunistic microorganism present and circulating in the veterinary hospital environment, of clinical importance and zooanthroponotic transmission of P. aeruginosa has also been reported. The aim of this study was to characterize the population of P. aeruginosa present in a veterinary hospital environment by evaluating their resistance profile and biofilm production.Materials, Methods & Results: A total of 306 samples were collected from the veterinary hospital environment (swabs from consultation tables, surgical tables, door handles, hospitalization cages, stethoscopes, thermometers, and muzzles). The isolates were biochemically identified as belonging to the species Pseudomonas aeruginosa through nitrate to nitrite reduction, motility and oxidase test, growth at 42°C, pigment production, and alkalinization of acetamide. Antimicrobial resistance was tested using the minimum inhibitory concentration (MIC) test. Twenty seven isolates of P. aeruginosa were obtained, with a frequency of 8.8%. The detection of beta-lactamase production and biofilm formation genes by polymerase chain reaction (PCR). Two multidrug resistant (MDR) and 3 single-drug resistant (SDR) strains of P. aeruginosa were identified. Furthermore, it was observed that the strains carried genes related to beta-lactamase production (TEM and CTX-M group 25) and biofilm production (pelA, pslA, ppyR).Discussion: Pseudomonas aeruginosa is considered a major cause of opportunistic hospital infections, as it causes significant morbidity and mortality in immunosuppressed individuals, both in animals and in humans. Veterinary hospitals can harbor microorganisms that cause infections, as well as multiresistant agents. Normally, these environments have a large circulation of people and animals, which particularly enables a facilitated dissemination of these resistant microorganisms. Recently, the World Health Organization (WHO) listed carbapenem-resistant P. aeruginosa as one of 3 bacterial species in critical need for the development of new antibiotics to treat their infections. The data found in this work strengthen the knowledge on the antimicrobial resistance capacity that P. aeruginosa exhibits. The presence of 3 multiresistant strains further highlights the advanced stage of resistance of this bacterial species. The characteri